One of the primary vehicles for kickbacks and fraud seems to be foundations associated with federal agencies. This article will highlight and expose yet another way we are being conned and manipulated by examining the Foundation for the National Institutes of Health1 (FNIH), whose board is plastered with major Big Pharma players.
This raises serious questions about conflicts of interest, seeing how the foundation oversees the distribution of hundreds of millions of dollars — unregulated funds that typically go right back into the coffers of the drug industry. It’s a very clever strategy to extract even more funds from the American taxpayers.
This conflict of interest also, at least in part, helps explain the actions of Dr. Anthony Fauci, director of the National Institutes of Allergy and Infectious Diseases (NIAID) and now-retired director of the NIH, Dr. Francis Collins.2 Both have gone out of their way to protect the makers of COVID shots and dismiss evidence that SARS-CoV-2 was created in and escaped from a lab.
We’ve got seven current or former drug company executives, the CDC, the FDA, the Sackler family (notorious for its creation of a deadly opioid epidemic), Johns Hopkins (co-sponsor of Event 201, which “predicted” COVID-19 and the subsequent destruction of human rights), and two major investment bankers, Goldman Sachs and BlackRock.
The inclusion of BlackRock is particularly interesting, and disturbing, considering they have a hidden monopoly on global asset holdings. Together with Vanguard, BlackRock has ownership in some 1,600 American firms, which in 2015 had combined revenues of $9.1 trillion. If you add in the third-largest global asset holder, State Street, their combined ownership encompasses nearly 90% of all S&P 500 firms.7 Just what is BlackRock doing on the FNIH’s board of directors?